eRX Mandate Takes Effect

Starting January 1, 2020, nearly all out-patient prescriptions in the State of Iowa must be issued electronically unless the prescriber has received a blanket waiver from the Board of Pharmacy (BOP) or the prescription qualifies for one of the
to this new mandate. IMS and the BOP have fielded numerous inquiries about the eRX mandate over the past few months. The BOP has published additional information, including FAQ documents, on its IMS has confirmed that there will be legislative efforts next session to expand the list of permissible exceptions to the mandate. If you have an example of a practice arrangement where you believe this prescribing mandate should not apply or for assistance in navigating this new practice requirement, please contact with the IMS Center for Physician Advocacy.

Recent News

Workforce in Action Engaging with Local Stakeholders

Last week, IMS and partners kicked off the first of the regional stakeholder meetings as part of the healthcare workforce initiative with the Iowa Department of Public Health...

Advocate 2020 Session - Week 5

Just one week remains until the first legislative funnel – the date by which nearly all policy bills must have passed a committee in their chamber of origin to remain viable for consideration this session...

Advocate 2020 Session - Week 4

Tort reform efforts continue to move forward at the capitol. On Wednesday, the House held a packed subcommittee meeting to consider HSB 596 – the bill to enact a hard cap on noneconomic damages...

Advocate 2020 Session - Week 3

The big news out of the capitol this week was the long-anticipated introduction of the companion bills to enact a hard cap on noneconomic damages in medical liability suits...

Physician Advocate of the Week Polk County Medical Society

Through the new Physician Advocate of the Week Program, you can come to the capitol any Wednesday during legislative session to lend your voice to the tort reform debate.

Got News?

Is there something you think we should be covering? What would you like to see IMS report on? Click here to let us know.